Reds-III

Ended Awarded Last action

Contract number
HHSN26800002
Awardee
Awarding agency
Obligated
$5,694,454

Award facts

Contract value 100% obligated
$5,694,454.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
San Francisco, CA 94118, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00011 $0
Change Order P00010 · DE-obligate unexpended funds in the amount of $310,689.39 for reallocation and repurposing. -$310,689
Other Administrative Action P00009 -$107,714
Change Order P00008 · Reds-III international site brazil $0
Other Administrative Action 7 · Reds-III - international (BRAZIL) -$111,049
Change Order 6 $0
Funding Only Action 5 · Recipient epidemiology and donor evaluation study III (REDS-III) - international site. $354,442
Funding Only Action 4 $111,016
Funding Only Action 3 $150,921
Change Order 2 $294,973
Other Administrative Action 1 $0
Original award $5,312,554
Show all 12

About this award

This delivery order against the REDS-III contract was awarded by the National Heart, Lung and Blood Institute to Vitalant Research Institute to support the REDS-III - International program in Brazil. Valued at $5.69 million, the effort involves establishing a sickle cell disease patient cohort and evaluating transfusion strategies and risks in Brazil. Vitalant will oversee clinical protocol implementation and data analysis in partnership with the University of Sao Paulo and blood collection sites in four Brazilian cities. Major subcontractors include UCSF Benioff Children's Hospital Oakland and the Fundacao Faculdade de Medicina to administer research activities. The contract runs from March 2013 through December 2019 to advance the National Institutes of Health's understanding of blood safety and availability issues internationally under the Rare Diseases Clinical Research Network.

Quick answers

Who was awarded contract HHSN26800002?

HHSN26800002 was awarded to Vitalant by National Heart Lung and Blood Institute (National Institutes of Health) on March 29, 2013.

How much is contract HHSN26800002 worth?

The government has obligated $5,694,454 on HHSN26800002.

Is contract HHSN26800002 an order under another contract?

Yes. HHSN26800002 is a delivery order under HHSN268201100007I, an indefinite delivery contract.

Was contract HHSN26800002 competed?

The extent of competition for HHSN26800002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award